All LABAs are associated with an increased risk of asthma-related deaths. Indacaterol is indicated for patients with COPD and not for patients with asthma. Indacaterol should not be used for ...

"Optimal management of asthma may be driven by patient values and preferences, balancing key benefits and key harms in these ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

If an inhaled steroid does not help or does not relieve your symptoms enough, current guidelines from the National Heart, Lung, and Blood Institute recommend adding a long-acting bronchodilator ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ...

Acute Asthma Episodes Flovent HFA is not to be regarded as a bronchodilator and is not indicated ... beta-agonists (short-acting [as needed or regularly scheduled] or long-acting), theophylline ...

Rinse mouth after each inhalation. Deterioration of Disease and Acute Asthma Episodes Pulmicort Flexhaler or Respules is not a bronchodilator and is not indicated for the rapid relief of acute ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Lindsay Curtis is a freelance health & medical writer in South Florida. Prior to becoming a freelancer, she worked as a communications professional for health nonprofits and the University of ...